Hasil Klinis Pasien COVID-19 dengan HIV
DOI:
https://doi.org/10.55175/cdk.v50i5.889Keywords:
COVID-19, HIV, penyakit menularAbstract
COVID-19 adalah penyakit menular yang telah menjadi krisis kesehatan utama sejak tahun 2020. Penyakit ini dikaitkan dengan banyak penyakit lain, termasuk human immunodeficiency virus (HIV). Kasus pada pria usia 33 tahun dengan riwayat HIV sejak tahun 2020 mengeluh batuk berdahak disertai bercak darah, nyeri menelan, demam intermiten, dan bercak putih di lidah. Hasil swab PCR COVID-19 positif dengan rontgen dada tampak normal. Evaluasi CD4 rutin setiap 6 bulan dengan nilai terakhir 312 sel/mm3. Pasien didiagnosis COVID-19 derajat sedang dan HIV. Terapi sesuai pedoman COVID-19 dan antiretroviral dengan prognosis baik.
COVID-19 is an contagious disease that has become a major health crisis since 2020. This disease is associated with many other diseases, including the human immunodeficiency virus (HIV). The case is a 33-year-old male with a history of HIV since 2020, complaining of a cough accompanied by blood-stained sputum, painful swallowing, intermittent fever, and white patches on the tongue. The COVID-19 PCR swab was positive with a normal chest X-ray. Routine CD4 evaluation every 6 months showed the latest value of 312 cells/mm3. The patient was diagnosed as moderate COVID-19 and HIV. Management is according to COVID-19 guidelines and antiretroviral with a good prognosis.
Downloads
References
Kementerian Kesehatan RI. Situasi terkini perkembangan coronavirus disease (Covid-19) 08 Agustus 2022 [Internet]. 2022. Available from: https://infeksiemerging.kemkes.go.id/situasi-infeksi-emerging/situasi-terkini-perkembangan-coronavirus-disease-covid-19-08-agustus-2022
Kementerian Kesehatan RI. Profil kesehatan Indonesia 2020 [Internet]. 2020. Available from: https://www.kemkes.go.id/downloads/resources/download/pusdatin/profil-kesehatan-indonesia/Profil-kesehatan-Indonesia-Tahun-2020.pdf
Lestari PE. Infeksi jamur candida pada penderita HIV/AIDS. Stomatognatic – J Kedokt Gigi 2015;10(1):35-8.
Mirzaei H, McFarland W, Karamouzian M, Sharifi H. COVID-19 among people living with HIV: A systematic review. AIDS Behav [Internet]. 2021;25(1):85–92.
Ambrosioni J, Blanco JL, Reyes-Urueña JM, Davies MA, Sued O, Marcos MA, et al. Overview of SARS-CoV-2 infection in adults living with HIV. Lancet HIV. 2021;8(5):294–305.
Danwang C, Noubiap JJ, Robert A, Yombi JC. Outcomes of patients with HIV and COVID-19 co-infection: A systematic review and meta-analysis. AIDS Res Ther. 2022;19(1):1–12.
Kementerian Kesehatan RI. Pedoman tatalaksana Covid-19. 4th Ed. Jakarta; 2022.
Peys E, Stevens D, Weygaerde YV, Malfait T, Hermie L, Rogiers P, et al. Haemoptysis as the first presentation of COVID-19: A case report. BMC Pulm Med 2020;20:275.
World Health Organization. Global tuberculosis report [Internet]. 2014. Available from: https://apps.who.int/iris/handle/10665/137094
Del Amo J, Polo R, Moreno S, Díaz A, Martínez E, Arribas J, et al. Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: A cohort study. Ann Intern Med. 2020;173:536–41.
Harter G, Spinner CD, Roider J, Bickel M, Krznaric I, Grunwald S, et al. COVID-19 in people living with human immunodeficiency virus: A case series of 33 patients. Infection 2020;48(5):681-6.
Dallocchio RN, Dessı A, De Vito A, Delogu G, Serra PA, Madeddu G. Early combination treatment with existing HIV antivirals: An effective treatment for COVID-19? Eur Rev Med Pharmacol Sci. 2021;25(5):2435–48.
Horby PW, Landray MJ. Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): A randomized, controlled, open-label, platform trial. Lancet 2020; 396(10259):1345–52.
WHO Solidarity Trial Consortium. Repurposed antiviral drugs for Covid-19 - Interim WHO solidarity trial results. New Engl J Med 2021;384(6):497-511.
Hariyanto TI, Putri C, Frinka P, Louisa J, Lugito NPH, Kurniawan A. Human immunodeficiency virus (HIV) and outcomes from coronavirus disease2019 (COVID-19) pneumonia: A meta-analysis and meta-regression. AIDS Res Hum Retroviruses [Internet]. 2021. Available from: https://www.liebertpub.com/doi/10.1089/AID.2020.0307?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed
Venturas J, Zamparini J, Shaddock E, Stacey S, Murray L, Richards GA, et al. Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19: HIV-positive and -negative patients with COVID-19. J Infect. 2021;83(2):217–27.
Bhaskaran K, Rentsch CT, MacKenna B, Schultze A, Mehrkar A, Bates CJ et al. HIV infection and COVID-19 death: A population-based cohort analysis of UK primary care data and linked national death registrations within the Open SAFELY platform. Lancet HIV. 2021;8:24-32.
Wilkinson RJ. Tuberculosis and type 2 diabetes mellitus: An inflammatory danger signal in the time of coronavirus disease 2019. Clin Infect Dis. 2021;72(1):79–81.
Jassat W, Cohen C, Masha M, Goldstein S, Kufa T, Savulescu D, et al. COVID-19 in-hospital mortality in South Africa: The intersection of communicableand non-communicable chronic diseases in a high HIV prevalence setting. medRxiv. 2020:2020.12.21.20248409. doi: 10.1101/2020.12.21.20248409.
World Health Organization. Fitur klinis dan faktor prognosis COVID-19 pada orang dengan HIV/AIDS yang dirawat sebagai suspek atau terkonfirmasi SARS-CoV-2. World Health Organization; 2021 .p. 12
Burhan E, Susanto AD, Nasution SA, Eka G, Pitoyo Ceva W, Susilo A, et al. Pedoman tatalaksana COVID-19 edisi 4; 2022 .p. 79–85.
Cooper TJ, Woodward BL, Alom S, Harky A. Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: A systematic review. HIV Medicine 2020;21(9):567–77.
Friedman EE, Devlin SA, McNulty MC, Ridgway JP. SARS-CoV-2 percent positivity and risk factors among people with HIV at an urban academic medical center. PLoS One 2021;16:1–11.
Hadi YB, Naqvi SFZ, Kupec JT, Sarwari AR. Characteristics and outcomes of COVID-19 in patients with HIV: A multicentre research network study. Aids 2020;34(13):3–8.
McCray E, Mermin J. Frequently asked questions about HIV and COVID-19 [Internet]. 2020 [cited 2022 August 25]. Available from: https://www.hiv.gov/blog/frequently-asked-questions-about-hiv-and-covid-19
PAPDI. Rekomendasi PAPDI tentang pemberian vaksinasi COVID-19 pada pasien dengan penyakit penyerta/ komorbid. Revisi 18 Maret 2021 [Internet]. 2021. Available from: https://www.papdi.or.id/berita/info-papdi/1024-rekomendasi-papdi-tentang-pemberian-vaksinasi-covid-19-pada-pasien-dengan-penyakit-penyerta-komorbid-revisi-18-maret-2021
Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, et al. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: A systematic review and meta-analysis. Sci Rep. 2021;11(1):1–12.
Tesoriero JM, Swain CAE, Pierce JL, Zamboni L, Wu M, Holtgrave DR, Gonzalez CJ, et al. COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York State. JAMA Network Open 2021;4(2):2037069. doi:10.1001/jamanetworkopen.2020.37069
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Cermin Dunia Kedokteran
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.